| Product NDC: | 0225-0295 |
| Proprietary Name: | ANASPAZ |
| Non Proprietary Name: | HYOSCYAMINE SULFATE |
| Active Ingredient(s): | .125 mg/1 & nbsp; HYOSCYAMINE SULFATE |
| Administration Route(s): | ORAL; SUBLINGUAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0225-0295 |
| Labeler Name: | BF ASCHER AND CO INC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 19730102 |
| Package NDC: | 0225-0295-15 |
| Package Description: | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0225-0295-15) |
| NDC Code | 0225-0295-15 |
| Proprietary Name | ANASPAZ |
| Package Description | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0225-0295-15) |
| Product NDC | 0225-0295 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | HYOSCYAMINE SULFATE |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL; SUBLINGUAL |
| Start Marketing Date | 19730102 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | BF ASCHER AND CO INC |
| Substance Name | HYOSCYAMINE SULFATE |
| Strength Number | .125 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |